INVO BioScience, Inc. (INVO) financial statements (2022 and earlier)

Company profile

Business Address 5582 BROADCAST COURT
SARASOTA, FL 34240
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,68510,0981,23921226152492
Cash and cash equivalents5,68510,0981,23921226152492
Receivables502282268731
Inventory, net of allowances, customer advances and progress billings28826510144598565
Inventory28826510144598565
Prepaid expense   2496311 
Other undisclosed current assets283158196    
Total current assets:6,30610,5431,543731234251559
Noncurrent Assets
Operating lease, right-of-use asset2,037  
Property, plant and equipment50113293341616 
Long-term investments and receivables1,490      
Long-term investments1,490      
Intangible assets, net (including goodwill)132      
Intangible assets, net (excluding goodwill)132      
Other noncurrent assets 27315912161921
Total noncurrent assets:4,16140525246323521
TOTAL ASSETS:10,46610,9471,795777266286580
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4438577653,0874,9164,5514,116
Accounts payable 3293725729619751,026
Employee-related liabilities5825273932,5153,9553,5763,090
Taxes payable 11    
Other undisclosed accounts payable and accrued liabilities(138)      
Deferred revenue6714714
Debt 15821132 1010
Due to related parties 65 9211211211
Contract with customer, liability19
Other undisclosed current liabilities804494 255   
Total current liabilities:1,2532,2881,5013,5025,1274,7724,337
Noncurrent Liabilities
Long-term debt and lease obligation1,90259407 132132 
Long-term debt, excluding current maturities  326 132132 
Operating lease, liability1,9025981
Liabilities, other than long-term debt12,8583,600    
Deferred revenue 2,8573,571
Deferred income tax liabilities10 
Due to related parties  29    
Other undisclosed noncurrent liabilities  0    
Total noncurrent liabilities:1,9032,9164,008 132132 
Total liabilities:3,1565,2045,5093,5025,2594,9044,337
Stockholders' equity
Stockholders' equity attributable to parent7,3115,743(3,714)(2,724)(4,992)(4,618)(3,757)
Common stock111615141414
Additional paid in capital46,20137,97820,16018,98213,63913,31112,048
Accumulated deficit(38,891)(32,236)(23,889)(21,721)(18,645)(17,943)(15,819)
Total stockholders' equity:7,3115,743(3,714)(2,724)(4,992)(4,618)(3,757)
TOTAL LIABILITIES AND EQUITY:10,46610,9471,795777266286580

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4,1601,0371,4804942825112
Cost of revenue(145)(89)(140)(90)(52)(15)(8)
Cost of goods and services sold(126)(79)  (52)(15)(8)
Gross profit:4,0159491,341404230364
Operating expenses(9,232)(6,463)(3,129)(3,038)(871)(2,146)(599)
Operating loss:(5,217)(5,515)(1,788)(2,634)(640)(2,110)(595)
Nonoperating expense(1,434)(2,832)(379)(442)(62)(14) 
Debt instrument, convertible, beneficial conversion feature   895   
Other nonoperating expense    (62)(14) 
Interest and debt expense159(2,837)(94)(442)(41)(14)(4,332)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 2,837944424114(32)
Loss from continuing operations before equity method investments, income taxes:(6,491)(8,347)(2,167)(3,076)(702)(2,124)(4,959)
Other undisclosed loss from continuing operations before income taxes(159)      
Loss from continuing operations before income taxes:(6,650)(8,347)(2,167)(3,076)(702)(2,124)(4,959)
Income tax expense(5)(0)(0) (1,680)  
Net loss:(6,655)(8,347)(2,168)(3,076)(2,382)(2,124)(4,959)
Other undisclosed net income attributable to parent    1,680  
Net loss available to common stockholders, diluted:(6,655)(8,347)(2,168)(3,076)(702)(2,124)(4,959)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(6,655)(8,347)(2,168)(3,076)(2,382)(2,124)(4,959)
Comprehensive loss, net of tax, attributable to parent:(6,655)(8,347)(2,168)(3,076)(2,382)(2,124)(4,959)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: